Patents by Inventor Jacob Gopas

Jacob Gopas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-QUORUM SENSING, ANTI-BIOFILM, AND INFLAMMATION ATTENUATING COMPOUNDS, COMPOSITIONS, AND METHODS OF USING SAME
    Publication number: 20240109855
    Abstract: The present invention is directed to compounds having anti quorum sensing activity, anti-inflammatory activity or both, compositions comprising same, and methods of using same, such for treating a subject afflicted with a disease.
    Type: Application
    Filed: January 13, 2022
    Publication date: April 4, 2024
    Inventors: Jacob GOPAS, Ariel KUSHMARO, Yael SHLICHTER, Rajendran SARAVANAKUMAR, Subramani MUTHURAMAN
  • NUPHARIDINE COMPOUNDS AND DERIVATIVES THEREOF FOR THE TREATMENT OF CYSTEINE PROTEASE RELATED DISEASES
    Publication number: 20180360810
    Abstract: Disclosed a method of treating a disease or a disorder characterized by protease activity. A pharmaceutical composition for treating a disease or a disorder characterized by protease activity is further disclosed. A method of detecting a cysteine protease from a biological sample is also disclosed.
    Type: Application
    Filed: December 8, 2016
    Publication date: December 20, 2018
    Inventors: Avi GOLAN-GOLDHIRSH, Jacob GOPAS, Udi ZURGIL
  • ANTI-MEASLES CANCER IMMUNOTHERAPY
    Publication number: 20160103130
    Abstract: The present invention provides methods for treating specific populations of cancer patients by immunotherapy. The methods comprise administering an immunogenic composition eliciting an immune response to measles virus to patients having measles virus-immunoreactive cancer cells.
    Type: Application
    Filed: October 13, 2015
    Publication date: April 14, 2016
    Inventors: Shmuel ARIAD, Jacob GOPAS, Daniel BENHARROCH, Irina LAZAREV
  • Methods and compositions for inhibiting the nuclear factor ?B pathway
    Patent number: 8945632
    Abstract: The current invention provides therapeutic methods which include inhibition of nuclear factor ?b pathway in a cell based on the discovery of an active fraction of a plant extract termed NUP or a composition which includes NUP. NUP is used in treating and managing different diseases such as cancer, inflammation, and virus infections.
    Type: Grant
    Filed: July 19, 2011
    Date of Patent: February 3, 2015
    Assignees: Ben Gurion University of the Negev R&D Authority, Mor Research Applications Ltd.
    Inventors: Avi Golan, Jacob Gopas, Janet Ozer, Nadav Eisner, Adelbert Bacher, Wolfgang Eisenreich, Elena Ostrozhenkova, Hila Winer
  • ANTI-MEASLES CANCER IMMUNOTHERAPY
    Publication number: 20140199344
    Abstract: The present invention provides methods for treating specific populations of cancer patients by immunotherapy. The methods comprise administering an immunogenic composition eliciting an immune response to measles virus to patients having measles virus-immunoreactive cancer cells.
    Type: Application
    Filed: March 18, 2014
    Publication date: July 17, 2014
    Applicant: MOR RESEARCH APPLICATIONS LTD.
    Inventors: Shmuel ARIAD, Jacob GOPAS, Daniel BENHARROCH, Irina LAZAREV
  • METHODS AND COMPOSITIONS FOR INHIBITING THE NUCLEAR FACTOR KAPPAB PATHWAY
    Publication number: 20130122114
    Abstract: The current invention provides therapeutic methods which include inhibition of nuclear factor ?b pathway in a cell based on the discovery of an active fraction of a plant extract termed NUP or a composition which includes NUP. NUP is used in treating and managing different diseases such as cancer, inflammation, and virus infections.
    Type: Application
    Filed: July 19, 2011
    Publication date: May 16, 2013
    Inventors: Avi Golan, Jacob Gopas, Janet Ozer, Nadav Eisner, Adelbert Bacher, Wolfgang Eisenreich, Elena Ostrozhenkova-Wangemann, Hila Winer
  • ANTI-MEASLES CANCER IMMUNOTHERAPY
    Publication number: 20110014231
    Abstract: The present invention provides methods for treating specific populations of cancer patients by immunotherapy. The methods comprise administering an immunogenic composition eliciting an immune response to measles virus to patients having measles virus-immunoreactive cancer cells.
    Type: Application
    Filed: November 5, 2008
    Publication date: January 20, 2011
    Applicant: MOR RESEARCH APPLICATIONS LTD
    Inventors: Shmuel Ariad, Jacob Gopas, Daniel Benharroch, Irina Lazarev